liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies
Umeå University, Sweden.
University of Marburg, Germany.
Linköping University, Department of Clinical and Experimental Medicine, Division of Neuro and Inflammation Science. Linköping University, Faculty of Medicine and Health Sciences.
University of Alberta, Canada.
Show others and affiliations
2015 (English)In: Journal of Allergy and Clinical Immunology, ISSN 0091-6749, E-ISSN 1097-6825, Vol. 135, no 1Article, review/survey (Refereed) Published
Abstract [en]

Rapid environmental transition and modern lifestyles are likely driving changes in the biodiversity of the human gut microbiota. With clear effects on physiologic, immunologic, and metabolic processes in human health, aberrations in the gut microbiome and intestinal homeostasis have the capacity for multisystem effects. Changes in microbial composition are implicated in the increasing propensity for a broad range of inflammatory diseases, such as allergic disease, asthma, inflammatory bowel disease (IBD), obesity, and associated noncommunicable diseases (NCDs). There are also suggestive implications for neurodevelopment and mental health. These diverse multisystem influences have sparked interest in strategies that might favorably modulate the gut microbiota to reduce the risk of many NCDs. For example, specific prebiotics promote favorable intestinal colonization, and their fermented products have anti-inflammatory properties. Specific probiotics also have immunomodulatory and metabolic effects. However, when evaluated in clinical trials, the effects are variable, preliminary, or limited in magnitude. Fecal microbiota transplantation is another emerging therapy that regulates inflammation in experimental models. In human subjects it has been successfully used in cases of Clostridium difficile infection and IBD, although controlled trials are lacking for IBD. Here we discuss relationships between gut colonization and inflammatory NCDs and gut microbiota modulation strategies for their treatment and prevention.

Place, publisher, year, edition, pages
Elsevier , 2015. Vol. 135, no 1
Keyword [en]
Fecal microbiota transplantation; gut microbiome; inflammation; noncommunicable diseases; prebiotics; probiotics; short-chain fatty acids
National Category
Gastroenterology and Hepatology
URN: urn:nbn:se:liu:diva-114013DOI: 10.1016/j.jaci.2014.11.012ISI: 000347298200001PubMedID: 25567038OAI: diva2:786786
Available from: 2015-02-06 Created: 2015-02-05 Last updated: 2016-03-23

Open Access in DiVA

fulltext(413 kB)389 downloads
File information
File name FULLTEXT01.pdfFile size 413 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Jenmalm, Maria
By organisation
Division of Neuro and Inflammation ScienceFaculty of Medicine and Health Sciences
In the same journal
Journal of Allergy and Clinical Immunology
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar
Total: 389 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 239 hits
ReferencesLink to record
Permanent link

Direct link